Art Howe is the founder of Imvax. Imvax has raised $238M in total funding. Latest round: Series C. Based in Philadelphia, Pennsylvania.
Art Howe is the Co-founder and CEO of Imvax, a clinical-stage biotechnology company focused on developing personalized immunotherapies for solid tumors. The company was founded using gene therapy vaccine technology developed by scientists at Thomas Jefferson University.
Full founder directory · Investor directory · Company funding database · Fundraising library